Abstract
It has been estimated that approximately 18 million episodes of bronchitis are treated in an ambulatory care setting in the United States each year.1 These inflammatory events produce troublesome symptoms, often result in absenteeism from work, and, on occasion, threaten the life of the patient. With the introduction of new culture and serological techniques, the infectious organisms contributing to actue bronchitis and the exacerbation of chronic bronchitis are being more completely defined. This chapter reviews contemporary concepts pertaining to the pathogenesis, microbiology, clinical features, differential diagnosis, therapy, and prevention of bronchitis in adults.
Chapter PDF
Similar content being viewed by others
Keywords
- Chronic Obstructive Pulmonary Disease
- Influenza Vaccine
- Chronic Bronchitis
- Clavulanic Acid
- Pneumococcal Vaccine
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Dixon RE: Economic costs of respiratory tract infections in the United States. Am J Med 1985; 78 (suppl 6B): 45 - 51.
Glick FH, Gregg MB, Berman B, et al: Pontiac fever. Am J Epidemiol 1978; 107: 149 - 160.
Grayston JT, Kuo CC, Wang SP, et al: A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986; 315: 161 - 168.
MacDonald KL, Osterholm MT, Hedberg CW, et al: Toxic shock syndrome: A newly recognized complication of influenza like illness. JAMA 1987; 257: 1052 - 1058.
Stott NCH, West RR: Randomised controlled trial of antibiotics in patients with cough and purulent sputum. Br Med J 1976: 2: 556 - 559.
Kuhn JJ, Hendley JO, Adams KF, et al: Antitussive effect of guaifenesin in young adults with natural colds. Chest 1982; 82: 7 - 13.
Horadam VW, Sharp JG, Similack JD, et al: Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function. Ann Intern Med 1981; 94: 454 - 458.
American Thoracic Society: Definitions and classification of chronic bronchitis, asthma and pulmonary emphysema. Am Rev Respir Dis 1962; 85: 762 - 768.
Willett EC, Green A, Stampfer MJ, et al: Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987; 317: 1303 - 1309.
Peto R, Speiger FE, Cochrane AL, et al: The relevance in adults of airflow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Am Rev Respir Dis 1983; 128: 491 - 500.
Camilli AE, Burrows B, Knudson RI, et al: Longitudinal changes in forced expiratory volume in one second in adults. Am Rev Respir Dis 1987; 135: 794 - 799.
Britten N, Davies JMC, Colley JRT: Early respiratory experience and subsequent cough and peak expiratory flow rate in 36 year old men and women. Br Bed J 1987; 294: 1317 - 1320.
Irwin RS, Erickson AD, Pratter MR, et al: Prediction of tracheobronchial colonization in current cigarette smokers with chronic obstructive bronchitis. J Infect Dis 1982; 145: 234 - 241.
Irwin RS, Corroa WM, Erickson AD, et al: Characterization by transtrachaeal aspiration of the tracheobronchial microflora during acute exacerbations of chronic obstructive bronchitis. Am Rev Respir Dis 1980; 121 (suppl): 150.
Musher DM, Kubitscheck KR, Crennan J, et al: Pneumonia and acute febrile tracheobronchitis due to Haemophilus influenzae. Ann Intern Med 1983; 99: 444 - 450.
Anthonisen NR, Manfreda J, Warren CPW, et al: Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196 - 204.
Mulks MH, Kamfeld SJ, Plant AG: Specific proteolysis of human IgA by Streptococcus pneumoniae and Haemophilus influenzae. J Infect Dis 1980; 141: 450 - 456.
Mulks MH, Plaut AG: IgA protease production as a characteristic distinguishing pathogenic from harmless Neisseriaceae. N Engl J Med 1978; 299: 973 - 976.
Musher DM, Goree A, Baughn RE, et al: Immunoglobulin A from bronchopulmonary secretions blocks bactericidal and opsonizing effects of antibody to nontypable Haemophilus influenzae. Infect Immun 1984; 45: 36 - 40.
Raheja AK, Weiss EB: The significance of fever in acute exacerbations of chronic obstructive airways disase. Am Rev Respir Dis 1981; 123 (Suppl): 71.
Nicotra MB, Rivera M, Awe RJ: Antibiotic therapy of acute exacerbations of chronic bronchitis. Ann Intern Med 1982; 97: 18 - 21.
Chodosh S: Acute bacterial exacerbations in bronchitis and asthma. Am J Med 1987; 82 (Suppl 4A): 154 - 163.
Chodosh S: Bacampicillin in chronic bronchitis: Clinical experience. Bull NY Acad Med 1983; 59: 505 - 514.
Pines A: Trimethoprim—sulfamethoxazole in the treatment and prevention of purulent exacerbations of chronic bronchitis. J Infect Dis 1973; 128 (Suppl): 706 - 709.
Cooper TJ, Ladusans E, Williams PEO, et al: A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infections. J Antimibroc Chemother 1985; 16: 373 - 378.
Rubinstein E, Segev S: Drug interactions of ciproflozacin with other nonantibiotic agents. Am J Med 1987; 82 (Suppl 4A): 119 - 123.
Albert RK, Martin TR, Lavois SW: Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med 1980; 92: 753 - 758.
Rice KL, Leatherman, JW, Duane PG, et al: Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 107: 305 - 309.
Leech JA, Gervais A, Rubin FL: Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease. Can Med Assoc J 1987; 136: 361 - 365.
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gleckman, R.A. (1988). Infectious Bronchitis. In: Infections in Outpatient Practice. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0780-6_6
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0780-6_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0782-0
Online ISBN: 978-1-4899-0780-6
eBook Packages: Springer Book Archive